openPR Logo
Press release

Peptide Based Infection Therapeutics Market Value to reach US$ 1.5 Bn by 2022

08-28-2017 09:24 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Peptide Based Infection Therapeutics Market Value to reach US$

Peptide therapeutic agents are novel solutions to treat infectious diseases. The peptide based infection therapeutics market is impacted by factors such as higher investment in healthcare industry, advancements in technologies, increase in biotech and pharmaceutical companies, the need for peptides to treat infections owing to the various advantages offered by peptides such as safety, reliability, stability, higher efficacy, cost effectiveness and easy synthesis due to small size, rising developments in drug discovery and the rising foreign direct investment in emerging economies. All the aspects influence the global peptide based infection therapeutics market in a positive way. North America region is expected to be the most lucrative region for the global peptide based infection therapeutics market.

The global peptide based infection therapeutics market is anticipated to show a value a shade less than US$ 1.5 Bn and expected to grow at a robust rate during the period of forecast.

6 Forecast Highlights on Global Peptide Based Infection Therapeutics Market

North America expected to show higher market attractiveness and domination over other regions in terms of market share by revenue. It has a higher value share and is poised to grow at a higher growth rate to reflect a CAGR of 8.4% throughout the forecast period, 2017 to 2022

Request For Report Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=188

Asia-Pacific excluding Japan (APEJ) shows the highest growth rate and poised to register a CAGR of 8.7% during the period of forecast, owing to rapid development and higher foreign direct investment in this region. Following APEJ, Europe region also reflects good rate of growth in the global peptide based infection therapeutics market

By drug class, telaprivir shows higher market share by revenue as compared to boceprevir. However, boceprivir shows a higher growth rate to reflect a CAGR of 8.2% during the period of forecast. It can be said that, even though telaprevir segment has a market share which is almost one and a half times than that of boceprevir, the boseprivir segment, could match the market share at this high growth rate post 2022, a market observation which would depend on the current growth rate of boceprivir and its consistency through 2017 to 2022 and even beyond

The online pharmacies segment by distribution channel shows the fastest growth rate and is poised to reflect a CAGR of 9.2% throughout the period of forecast of 2017 to 2022. Yet, this segment shows less market share by revenue as compared to other segments.

Request For Discount: https://www.factmr.com/connectus/sample?flag=D&rep_id=188

The hospital pharmacy segment enjoys the highest market revenue share followed by retail pharmacy segment. The retail pharmacy segment, however, reflects a higher growth rate as compared to the hospital pharmacy segment. It would be only appropriate to track these two segments who have a toe to toe competition, in order to check the scenarios by the end of 2022

The online pharmacies segment finds North America region to be the most lucrative and has the highest growth in this region comparatively. The APEJ region is much favorable for the hospital and retail pharmacies segment followed by Europe. Latin America and Middle East and Africa region show less attractiveness comparatively

The report has also profiled leading players in the global market for peptide based infection therapeutics, which would remain active through 2022. These include companies like Parchem Fine & Specialty Chemicals, Merck & Co., Inc. and Vertex Pharmaceuticals Incorporated.

Browse Full Report: https://www.factmr.com/report/188/peptide-based-infection-therapeutics-market

ABOUT US:
Fact.MR is focused on offering transformative intelligence that inspires breakthroughs and innovation. We believe that the right decisions at the opportune time are integral to achieve extraordinary success. We are here to help you with your strategic decision making.

CONTACT:
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Phone: +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide Based Infection Therapeutics Market Value to reach US$ 1.5 Bn by 2022 here

News-ID: 686046 • Views:

More Releases from Fact.MR

Fiber Optic Gyroscope Market to Hit US$ 1,760.9 Million with 6.2% CAGR Growth by 2032
Fiber Optic Gyroscope Market to Hit US$ 1,760.9 Million with 6.2% CAGR Growth by …
The fiber optic gyroscopes market is still expanding due to the need for dependable equipment for military and aerospace applications. With a compound annual growth rate (CAGR) of 6.2%, the global fiber optic gyroscope market is projected to reach a valuation of US$ 968.2 million in 2022 and US$ 1,760.9 million by the end of 2032. The market for fiber optic gyroscopes is anticipated to grow as a result of the
Active Pharmaceutical Ingredient Market Size to Surpass US$ 307.5 Billion Growth by 2034, Exhibit a CAGR of 4% |Fact.MR
03-29-2024 | Health & Medicine
Fact.MR
Active Pharmaceutical Ingredient Market Size to Surpass US$ 307.5 Billion Growth …
The global active pharmaceutical ingredients market (医薬品原薬市場) is valued at US$ 207.9 billion in 2024 and is expected to reach US$ 307.5 billion by the end of 2034. It represents a constant growth and annual growth rate (CAGR) of 4% for ten years from 2024 to 2034. Markets act as a fundamental cornerstone of the pharmaceutical industry and play an important role in achieving the therapeutic effect of drugs. Active pharmaceutical
Ambulance Stretcher Market to Hit US$ 273.4 Million at CAGR of 0.7% by 2034 |Fact.MR
03-29-2024 | Health & Medicine
Fact.MR
Ambulance Stretcher Market to Hit US$ 273.4 Million at CAGR of 0.7% by 2034 |Fac …
The global ambulance stretcher market is currently valued at USD 254.2 million by 2024. During the forecast period to 2034, the market is expected to grow gradually at a modest compound annual growth rate (CAGR) of 0.7% to reach USD 273.4 million by the end of 2034. This growth is due to a number of factors such as demographic changes, advances in health technology and increasing demand for efficient emergency
Elevators Market to Grow at 11% CAGR, Reaching $270 Billion by 2033
Elevators Market to Grow at 11% CAGR, Reaching $270 Billion by 2033
The international elevators market (エレベーター市場) got to an evaluation of United States $ 95 billion in 2023 as well as is predicted to get to United States $ 270 billion by the end of 2033. This market is anticipated to expand at a substantial CAGR of 11% from 2023 to 2033. The elevators market stands as a crucial cog in the wheel of contemporary facilities, promoting upright mobility in significantly metropolitan

All 5 Releases


More Releases for Peptide

Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established
What's driving the Customized Peptide Synthesis Market Growth? | Key Players are …
The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology. Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample There are two main types of products available in the customized peptide synthesis
Customized Peptide Synthesis Market 2019-2024 by Top Key Players are GenScript, …
Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology. Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected
Peptide Synthesis Market Increasing Demand & Latest Trend with Genscript, AnaSpe …
HTF MI recently introduced United States Peptide Synthesis Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript,
Global Peptide Therapeutics Market: Cancer Treatment to Surface as Key Applicati …
Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future. Click to Request a Sample:
Peptide Based Cancer Therapeutics Marke For peptide based cancer therapeutics ov …
About Peptide Based Cancer Therapeutics Market Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug